You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Bacterial Agent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and

Not yet recruiting
  • Disability or Chronic Disease Leading to Disablement
  • +2 more
  • Surgical flap and anti-bacterial agents
  • Garches, France
    Department of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023

Ulcerative Colitis Trial in Al Minya (Saffron, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Al Minyā, Minia, Egypt
    Minia University
Feb 3, 2023

Axial Spondyloarthritis Trial in Besançon (Blood sample, anti-TNF antibody administration, anti-IL-17 antibody administration)

Recruiting
  • Axial Spondyloarthritis
  • Blood sample
  • +2 more
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
May 31, 2022

Lumbar Disc Disease, Epidural Fibrosis, Failed Back Surgery Syndrome Trial in Pathum Wan (Mediclore, Normal Saline)

Not yet recruiting
  • Lumbar Disc Disease
  • +2 more
  • Pathum Wan, Bangkok, Thailand
    King Chulalongkorn Memorial Hospital
Sep 12, 2023

Adhesion Trial in New Taipei City (Use 4DryField)

Recruiting
  • Adhesion
  • Use 4DryField
  • New Taipei City, Taiwan
    Taipei Medical University Shuang-Ho Hospital
Oct 12, 2022

Neutropenia, Febrile, Hematologic Cancer Trial in Doha (Ceftolozane-tazobactam IV)

Not yet recruiting
  • Neutropenia, Febrile
  • Hematologic Cancer
  • Ceftolozane-tazobactam IV
  • Doha, Qatar
    Hamad Medical Corporation, National Center for Cancer Care and R
Apr 7, 2022

Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

Not yet recruiting
  • Esophagus Cancer
  • +4 more
  • Intravenous injection of P-IL-2
  • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
  • (no location specified)
Apr 24, 2023

Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)

Not yet recruiting
  • Advanced Solid Tumors
  • LCB84
  • Anti-PD-1 monoclonal antibody
  • Los Angeles, California
  • +6 more
Jul 4, 2023

Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

Not yet recruiting
  • Salivary Gland Cancer
  • vedicitumomab (Edisil, RC48）
  • +3 more
  • (no location specified)
Jun 9, 2023

Gingival Inflammation Trial in Mansoura (titanium dioxide nanoparticles in test group)

Completed
  • Gingival Inflammation
  • titanium dioxide nanoparticles in test group
  • Mansoura, Egypt
    Mansoura university
Sep 25, 2023

Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)

Recruiting
  • Community-acquired Pneumonia
  • Bacterial Pneumonia
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Jan 20, 2023

Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)

Recruiting
  • Solid Tumor
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital
Jun 14, 2023

Thyroidectomy, Goiter, Thyroid Cancer Trial in Taipei (Oxidized regenerated cellulose(ORC), Hyaluronic acid(HA))

Recruiting
  • Thyroidectomy
  • +2 more
  • Oxidized regenerated cellulose(ORC)
  • Hyaluronic acid(HA)
  • Taipei, Taiwan
    National Taiwan University Hospital
May 1, 2023

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Advanced Solid Tumor Trial in Kuching (BL0020)

Not yet recruiting
  • Advanced Solid Tumor
  • Kuching, Malaysia
    Sarawak General Hospital
May 24, 2023

Renal Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer Trial (HFB200603, Tislelizumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • (no location specified)
Mar 15, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

Not yet recruiting
  • Macular Degeneration, Age Related
  • +4 more
  • VISUPRIME
  • Placebo
  • Perugia, PG, Italy
    Ospedale Santa Maria della Misericordia
Dec 22, 2022

Overweight and Obesity, Hypercholesterolemia, Hypertriglyceridemia Trial in Murcia (Silibinin A)

Active, not recruiting
  • Overweight and Obesity
  • +2 more
  • Silibinin A
  • Murcia, Spain
    Faculty of Nursing. Catholic University of Murcia
May 17, 2022

Overweight and Obesity Trial in Lahore (Phaseolus Vulgaris, Placebo)

Not yet recruiting
  • Overweight and Obesity
  • Phaseolus Vulgaris
  • Placebo
  • Lahore, Punjab, Pakistan
  • +1 more
Jul 6, 2022

Oral-facial Pain Trial in Catania (Palmitoyletinolamide, Placebo)

Recruiting
  • Oral-facial Pain
  • Palmitoyletinolamide
  • Placebo
  • Catania, Italy
    AOU Policlinico G. Rodolico
May 23, 2023

Metastatic Cancer, Unresectable Malignant Tumor Trial in Groningen (Anti-CD8 PET imaging agent)

Recruiting
  • Metastatic Cancer
  • Unresectable Malignant Neoplasm
  • Anti-CD8 PET imaging agent
  • Groningen, Netherlands
    University Medical Center Groningen
Mar 1, 2022

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

PRP, Losartan, Muscle Injury Trial (Autologous platelets rich plasma, Autologous platelets rich plasma + oral LOSARTAN

Completed
  • PRP
  • +3 more
  • Autologous platelets rich plasma
  • Autologous platelets rich plasma + oral LOSARTAN administration
  • (no location specified)
Apr 12, 2023

Hypertension Trial in San Francisco (Anti-hypertensive agent: amlodipine, Anti-hypertensive agent: Chlorthalidone,

Recruiting
  • Hypertension
  • Anti-hypertensive agent: amlodipine
  • +5 more
  • San Francisco, California
    University of California San Francisco
May 6, 2022